Drug Profile
Ibuprofen - PLx Pharma
Alternative Names: IBU-PC; Ibuprofen-PC; Ibuprofen-phosphatidylcholine; PL 1100; ZavrylLatest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator PLx Pharma
- Class Amines; Analgesics; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Inflammation; Pain
Most Recent Events
- 17 Jun 2021 Phase II development for Pain and inflammation is still ongoing in USA (PO) (PLx Pharma's pipeline, June 2021)
- 15 Jun 2018 Chemical structure information added
- 20 Oct 2017 Phase-II development is ongoing for Pain and Inflammation (associated with Osteoarthritis and Rheumatoid arthritis) (PLx Pharma pipeline, October 2017)